Clinigen (CLIN:AIM)
547.5pGain to date: 140.9%The speciality pharmaceutical and service group's unbroken ascent since its 2012 market debut has come to an end. But investors should hold tight despite Clinigen's (CLIN:AIM) near 20% retreat following a...
06 March 2014